SCHEMBL6579405

SCHEMBL6579405

Cc1ccc(F)cc1Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@](C)(O)CC2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.62
BRDT Q58F21 3/20 0.62
MAPK14 Q16539 17/20 0.61
BRD2 P25440 1/20 0.59
BRD3 Q15059 1/20 0.59
KDM4E B2RXH2 1/20 0.50
MAPK13 O15264 1/20 0.50
PRKD3 O94806 1/20 0.50
MAP4K4 O95819 1/20 0.50
EGFR P00533 1/20 0.50
RAF1 P04049 1/20 0.50
CYP1A2 P05177 1/20 0.50
LCK P06239 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
PRKCA P17252 1/20 0.50
CYP2C19 P33261 1/20 0.50
FRK P42685 1/20 0.50
MAPK9 P45984 1/20 0.50
CSNK1A1 P48729 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6576824 1.00 BRD4 (0.62) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6576610 1.00 BRD4 (0.62) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6579234 0.93 MAPK14 (0.61) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6579097 0.93 MAPK14 (0.61) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6579102 0.93 MAPK14 (0.61) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6581214 0.90 MAPK14 (0.73) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6581217 0.90 MAPK14 (0.73) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6576809 0.90 MAPK14 (0.73) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6577075 0.89 MAPK14 (0.60) BRD4BRDTMAPK14BRD2BRD3
SCHEMBL6579817 0.89 MAPK14 (0.60) BRD4BRDTMAPK14BRD2BRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0961618-B1 5-Pyrimidinyl-4-yl-Imidazole Derivate zur Behandlung von CSBP/RK/p38 vermittelten Erkrankungen SMITHKLINE BEECHAM CORP (US) 2004-08-04 EP claimed